SITE MAP   |   CONTACT US


header
VASERETIC® (enalapril maleate/hydrochlorothiazide) combines an angiotensin converting enzyme inhibitor (ACE inhibitor), enalapril maleate, and the water pill (diuretic) called hydrochlorothiazide. This product is indicated for the treatment of high blood pressure (hypertension). VASERETIC® 10-25 is available in the tablet combination containing 10mg enalapril maleate and 25mg hydrochlorothiazide.

Effective March 1, 2007, there was a change in the appearance to the tablets for VASERETIC®. There is no change to the medication in the tablets.  Please view the file below for new VASERETIC® images. 

USE IN PREGNANCY: When used in pregnancy during the second and third trimesters, ACE inhibitors can cause injury and even death to the developing fetus. When pregnancy is detected, VASERETIC® should be discontinued as soon as possible. See WARNINGS, Fetal/Neonatal Morbidity and Mortality.

For important information about VASERETIC®, please see Prescribing Information
  
Product information on this page is intended for residents of the U.S. only. Residents of Canada should return to the User Profile Selection page and select accordingly.

If you have medical information questions or need to report an adverse event or product complaint, please contact the Biovail Medical Communications Center at 1-866-BIOVAIL (246-8245), option 3 by phone, or (908) 927-1850 by fax, or Email Med.Comm@BIOVAIL.com

Resources





© 2007 Biovail Corporation - All Rights Reserved (BIO113B0602) Privacy Policy   |   Disclaimers